Trials invited submission of manuscripts, long and short, including Letters and Commentaries detailing the enforced changes to trial design; trial management; recruitment; consent process; intervention delivery and follow up as a result of the COVID-19 pandemic. We also welcomed the submission of Updates to protocols previously published in Trials that describe changes made because of the COVID-19 pandemic. This collection closed to new submissions on 31st July 2022.
Do hospitals that participate in COVID-19 research differ from non-trial hospitals? A cross-sectional study of US hospitals
To compare hospitals that did and did not participate in clinical trials evaluating potential inpatient COVID-19 therapeutics.